28
Participants
Start Date
September 30, 2008
Primary Completion Date
September 30, 2010
Study Completion Date
March 31, 2011
Adalimumab
Adalimumab 40 mg sub-cutaneously every two weeks
Centre de Recherche Clinique Ethienne Lebel, Fleurimont
Collaborators (1)
Abbott
INDUSTRY
Université de Sherbrooke
OTHER